NDC 0603-3741

NDC 0603-3741

NDC 0603-3741 is a in the category. It is labeled and distributed by .

Proprietary NameNDC 0603-3741
Marketing Category/

Packaging

NDC SPL Data Element Entries

NDC 0603-3741-28 [00603374128]

Furosemide TABLET
Marketing CategoryANDA
Application NumberANDA076796
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2004-03-26
Marketing End Date2018-07-31

NDC 0603-3741-21 [00603374121]

Furosemide TABLET
Marketing CategoryANDA
Application NumberANDA076796
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2004-03-26
Marketing End Date2018-07-31

NDC 0603-3741-02 [00603374102]

Furosemide TABLET
Marketing CategoryANDA
Application NumberANDA076796
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2011-09-26
Marketing End Date2016-04-21

NDC 0603-3741-10 [00603374110]

Furosemide TABLET
Marketing CategoryANDA
Application NumberANDA076796
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2004-03-26
Marketing End Date2016-04-21

NDC 0603-3741-04 [00603374104]

Furosemide TABLET
Marketing CategoryANDA
Application NumberANDA076796
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2011-09-26
Marketing End Date2016-04-21

NDC 0603-3741-32 [00603374132]

Furosemide TABLET
Marketing CategoryANDA
Application NumberANDA076796
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2004-03-26
Marketing End Date2018-07-31

Drug Details

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.